Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bausch & Lomb (BLCO) EBT (2021 - 2025)

Bausch & Lomb (BLCO) has disclosed EBT for 5 consecutive years, with $13.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT rose 230.0% year-over-year to $13.0 million, compared with a TTM value of -$317.0 million through Dec 2025, down 35.47%, and an annual FY2025 reading of -$317.0 million, down 35.47% over the prior year.
  • EBT was $13.0 million for Q4 2025 at Bausch & Lomb, up from -$3.0 million in the prior quarter.
  • Across five years, EBT topped out at $88.0 million in Q3 2021 and bottomed at -$180.0 million in Q1 2025.
  • Average EBT over 5 years is -$16.3 million, with a median of -$6.5 million recorded in 2024.
  • The sharpest move saw EBT plummeted 2750.0% in 2023, then skyrocketed 230.0% in 2025.
  • Year by year, EBT stood at $86.0 million in 2021, then plummeted by 102.33% to -$2.0 million in 2022, then tumbled by 2750.0% to -$57.0 million in 2023, then surged by 82.46% to -$10.0 million in 2024, then surged by 230.0% to $13.0 million in 2025.
  • Business Quant data shows EBT for BLCO at $13.0 million in Q4 2025, -$3.0 million in Q3 2025, and -$147.0 million in Q2 2025.